Association of Pulmonary Function with Osteosarcopenic Obesity in Older Adults Aged over 50 Years.
Han Sol LimDong-Kun KimHyun-Il GilMi-Yeon LeeHyun-Seung LeeYong-Taek LeeKyung Jae YoonChul-Hyun ParkPublished in: Nutrients (2023)
Osteosarcopenic obesity (OSO) is a newly described coexistence of osteopenia/osteoporosis, sarcopenia, and obesity. We examined the association between pulmonary function, OSO, and its composition in adults aged ≥ 50 years. A total of 26,343 participants (8640 men; 17,703 women) were classified into four groups based on the number of abnormal body compositions (osteopenia/osteoporosis, sarcopenia, and obesity): 0 (control), 1+, 2+, and 3+ (OSO) abnormal body compositions. The values of forced volume vital capacity (FVC)%, forced expiratory volume in 1 s (FEV1%), and FEV1/FVC% were significantly decreased by increasing the number of adverse body compositions ( p < 0.0001). Although the prevalence of restrictive spirometry pattern (RSP) was positively associated with a higher number of abnormal body composition parameters ( p < 0.001), obstructive spirometry pattern (OSP) had no association with adverse body composition. In multivariate analyses, the adjusted odds ratios (ORs) for RSP compared to the control group were 1.36 in 1+, 1.47 in 2+, and 1.64 in 3+ abnormal body compositions ( p for trend < 0.001). Multiple abnormal body composition, especially osteosarcopenic obesity, was independently associated with poor lung function showing RSP in older adults over 50 years. The coexistence of these abnormal body compositions may be a predisposing factor for pulmonary function deterioration.
Keyphrases
- body composition
- bone mineral density
- lung function
- insulin resistance
- metabolic syndrome
- weight loss
- resistance training
- high fat diet induced
- type diabetes
- weight gain
- postmenopausal women
- cystic fibrosis
- chronic obstructive pulmonary disease
- adipose tissue
- air pollution
- mechanical ventilation
- risk factors
- body mass index
- intensive care unit
- pregnant women
- acute respiratory distress syndrome
- middle aged
- data analysis
- adverse drug